menu search

Leading independent proxy advisory firm iss recommends paratek pharmaceuticals stockholders vote for the acquisition by gurnet point capital and novo holdings

BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (“Paratek”) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company...

September 7, 2023, 7:34 pm

Lifshitz law pllc announces investigations of prtk, cir, reun, and fate

NEW YORK, June 10, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) Lifshitz Law PLLC announces an investigation into possible b...

June 11, 2023, 12:11 am

Paratek pharmaceuticals to be acquired by gurnet point capital and novo holdings

Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3.00 per Share of Common Stock, Including Up...

June 6, 2023, 1:05 pm


Search within

Pages Search Results: